Announced Wed, 12 Aug · 17:07 IST
Speciality Medicines gets approval for 2 new products in Ethiopia
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+1.6%1-day move
₹160.00
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+1.6+2.5+5.0+2.0-2.2—————
Up moveDown movePending
AI summary
Speciality Medicines Limited has received regulatory approval from Ethiopia's health authority for two new speciality pharmaceutical formulations: Olanzapine Tablets 5 mg (Olazyn 5) and Diazepam Tablets 5 mg (Diazem 5). With this addition, the company's total registered products in Ethiopia stand at 12 formulations, alongside 2 in Peru. The company is an exporter of speciality pharma products to regulated and semi-regulated global markets.
Likely market impact
Strengthens international product portfolio in Ethiopia; positive for export growth, though no revenue or order value details provided.